For citations:
Goroshkova M.Yu., Rumyantseva Yu.V., Aleinikova O.V., Dudkin S.A., Fechina L.G., Shamardina A.V., Streneva O.V., Kondratchik K.L., Minkina L.M., Lapotentova E.S., Inyushkina E.V., Kozlova O.B., Zhukovskaya E.V., Khlebnikova O.P., Basharova E.V., Timofeeva V.N., Pavlova G.P., Zlobina V.D., Utrobina O.A., Banshchikova E.S., Aslanyan K.S., Kondakova E.V., Tselousova E.V., Myakova N.V., Turobova T.V., Ryskal O.V., Fuks O.Yu., Lebedev V.V., Chipsanova N.F., Varfolomeeva S.R., Karachunsky A.I. Optimization of native E. coli-asparaginase therapy in standard risk-group children with acute lymphoblastic leukemia treated by the ALL-MB 2002 protocol. Oncohematology. 2008;(3):25-33. (In Russ.) https://doi.org/10.17650/1818-8346-2008-0-3-25-33
Email this article 